Florida Senate - 2016 COMMITTEE AMENDMENT
Bill No. CS for SB 938
Ì526230nÎ526230
LEGISLATIVE ACTION
Senate . House
Comm: RCS .
02/16/2016 .
.
.
.
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
The Committee on Commerce and Tourism (Bean) recommended the
following:
1 Senate Amendment
2
3 Delete lines 53 - 66
4 and insert:
5 a finished drug product containing any quantity of
6 dextromethorphan in violation of this section is subject to a
7 written warning for an initial violation and, for each
8 subsequent violation, a civil citation imposing a fine of not
9 more than $100, which shall accrue and may be recovered in a
10 civil action brought by the local jurisdiction. A manufacturer,
11 distributor, or retailer who demonstrates a good faith effort to
12 comply with this section is not subject to citation.
13 (b) An employee or representative of a manufacturer,
14 distributor, or retailer who, during the course of the
15 employee’s or representative’s employment or association with
16 the manufacturer, distributor, or retailer, sells a finished
17 drug product containing any quantity of dextromethorphan in
18 violation of this section is subject to a written warning.
19 (c) A person who possesses or receives a finished drug
20 product containing any quantity of dextromethorphan in